RNA Splicing Events in Circulation Distinguish Individuals With and Without New-onset Type 1 Diabetes

被引:1
|
作者
Webb-Robertson, Bobbie-Jo M. [1 ]
Wu, Wenting [2 ]
Flores, Javier E. [1 ]
Bramer, Lisa M. [1 ]
Syed, Farooq [2 ]
Tersey, Sarah A. [3 ,4 ]
May, Sarah C. [3 ,4 ]
Sims, Emily K. [2 ]
Evans-Molina, Carmella [2 ,5 ]
Mirmira, Raghavendra G. [3 ,4 ]
机构
[1] Pacific Northwest Natl Lab, Biol Sci Div, Richland, WA 99354 USA
[2] Indiana Univ Sch Med, Ctr Diabet & Metab Dis, Indianapolis, IN 46202 USA
[3] Univ Chicago, Diabet Res & Training Ctr, Chicago, IL 60637 USA
[4] Univ Chicago, Dept Med, Chicago, IL 60637 USA
[5] Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA
基金
美国国家卫生研究院;
关键词
type; 1; diabetes; machine learning; alternative RNA splicing; biomarkers; RECEPTOR;
D O I
10.1210/clinem/dgae622
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Alterations in RNA splicing may influence protein isoform diversity that contributes to or reflects the pathophysiology of certain diseases. Whereas specific RNA splicing events in pancreatic islets have been investigated in models of inflammation in vitro, how RNA splicing in the circulation correlates with or is reflective of type 1 diabetes (T1D) disease pathophysiology in humans remains unexplored.Objective To use machine learning to investigate if alternative RNA splicing events differ between individuals with and without new-onset T1D and to determine if these splicing events provide insight into T1D pathophysiology.Methods RNA deep sequencing was performed on whole blood samples from 2 independent cohorts: a training cohort consisting of 12 individuals with new-onset T1D and 12 age- and sex-matched nondiabetic controls and a validation cohort of the same size and demographics. Machine learning analysis was used to identify specific isoforms that could distinguish individuals with T1D from controls.Results Distinct patterns of RNA splicing differentiated participants with T1D from unaffected controls. Notably, certain splicing events, particularly involving retained introns, showed significant association with T1D. Machine learning analysis using these splicing events as features from the training cohort demonstrated high accuracy in distinguishing between T1D subjects and controls in the validation cohort. Gene Ontology pathway enrichment analysis of the retained intron category showed evidence for a systemic viral response in T1D subjects.Conclusion Alternative RNA splicing events in whole blood are significantly enriched in individuals with new-onset T1D and can effectively distinguish these individuals from unaffected controls. Our findings also suggest that RNA splicing profiles offer the potential to provide insights into disease pathogenesis.
引用
收藏
页码:1148 / 1157
页数:10
相关论文
共 50 条
  • [21] The Examination of the Relationship Between COVID-19 and New-Onset Type 1 Diabetes Mellitus in Children
    Donbaloglu, Zeynep
    Tuhan, Hale
    Kara, Tugce Tural
    Bedel, Aynur
    Cetiner, Ebru Barsal
    Singin, Berna
    Parlak, Mesyt
    TURKISH ARCHIVES OF PEDIATRICS, 2022, 57 (02): : 222 - 227
  • [22] Effects of Anacetrapib on the Incidence of New-Onset Diabetes Mellitus and on Vascular Events in People With Diabetes
    Bowman, Louise
    Landray, Martin
    CIRCULATION, 2017, 136 (24) : E451 - E451
  • [23] Diabetes cataract in a 10-year-old girl with new-onset type 1 diabetes mellitus
    Quintos, Jose Bernardo
    Torga, Ana Patricia
    Simon, Melissa A.
    BMJ CASE REPORTS, 2019, 12 (01)
  • [24] Immunoregulatory dendritic cells to prevent and reverse new-onset Type 1 diabetes mellitus
    Trucco, Massimo
    Giannoukakis, Nick
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (07) : 951 - 963
  • [25] Fatty acid-binding protein 4: a key regulator of ketoacidosis in new-onset type 1 diabetes
    Gruber, Noah
    Rathaus, Moran
    Ron, Idit
    Livne, Rinat
    Sheinvald, Sharon
    Barhod, Ehud
    Hemi, Rina
    Tirosh, Amit
    Pinhas-Hamiel, Orit
    Tirosh, Amir
    DIABETOLOGIA, 2022, 65 (02) : 366 - 374
  • [26] Circulating metabolomic and lipidomic changes in subjects with new-onset type 1 diabetes after optimization of glycemic control
    Julve, Josep
    Genua, Idoia
    Quifer-Rada, Paola
    Yanes, Oscar
    Barranco-Altirriba, Maria
    Hernandez, Marta
    Junza, Alexandra
    Capellades, Jordi
    Granado-Casas, Minerva
    Alonso, Nuria
    Castelblanco, Esmeralda
    Mauricio, Didac
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 197
  • [27] DKA and new-onset type 1 diabetes in Brazilian children and adolescents during the COVID-19 pandemic
    Luciano, Thais Milioni
    Halah, Mariana Peduti
    Alves Sarti, Mariana Teresa
    Floriano, Vitor Goncalves
    Lopes da Fonseca, Benedito Antonio
    Liberatore Junior, Raphael Del Roio
    Antonini, Sonir Rauber
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2022, 66 (01): : 88 - 91
  • [28] Clinically Serious Hypoglycemia Is Rare and Not Associated With Time-in-range in Youth With New-onset Type 1 Diabetes
    Addala, Ananta
    Zaharieva, Dessi P.
    Gu, Angela J.
    Prahalad, Priya
    Scheinker, David
    Buckingham, Bruce
    Hood, Korey K.
    Maahs, David M.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (11) : 3239 - 3247
  • [29] Severity of new-onset type 1 diabetes in children and adolescents during the coronavirus-19 disease pandemic
    Jose Rivero-Martin, Maria
    Maria Rivas-Mercado, Carmen
    Jesus Cenal-Gonzalez-Fierro, Maria
    Lopez-Barrena, Nuria
    Lara-Orejas, Emma
    Alonso-Martin, Daniel
    Alfaro-Iznaola, Cristina
    Jose Alcazar-Villar, Maria
    Sanchez-Escudero, Veronica
    Gonzalez-Vergaz, Amparo
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2022, 69 (10): : 810 - 815
  • [30] A Correlational Study on Cardiopulmonary Endurance in Male Patients with New-Onset Type 2 Diabetes
    Liu, Bin-Bin
    Niu, Zi-Ru
    Jia, Xiao-Jiao
    Liu, Xiao-Li
    Lu, Qiang
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2022, 15 : 1365 - 1373